Used in the synthesis of pharmaceutical intermediates, particularly in the development of central nervous system agents. It serves as a key building block in the preparation of benzazepine derivatives, which exhibit biological activity such as dopamine receptor modulation. Its structure supports the creation of compounds being investigated for neurological and psychiatric disorders, including schizophrenia and Parkinson’s disease. Also employed in research settings for structure-activity relationship studies due to its ability to form stable oxime derivatives with tunable pharmacokinetic properties.